Mc Ilrath & Eck, LLC Amgen Inc Transaction History

Mc Ilrath & Eck, LLC

$574 Million
Q3 2024

A detailed history of Mc Ilrath & Eck, LLC transactions in Amgen Inc stock. As of the latest transaction made, Mc Ilrath & Eck, LLC holds 1,087 shares of AMGN stock, worth $283,946. This represents 0.06% of its overall portfolio holdings.

Number of Shares

1,087

Previous 1,077 0.93%

Holding current value

$283,946

Previous $336,000 4.17%

% of portfolio

0.06%

Previous 0.07%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 19, 2024	BUY	$309.38 - $337.38 $3,093 - $3,373	10 Added 0.93%	1,087 $350,000
Q2 2024 Aug 13, 2024	SELL	$262.75 - $319.31 $5,517 - $6,705	-21 Reduced 1.91%	1,077 $336,000
Q1 2024 May 10, 2024	BUY	$268.87 - $324.56 $47,321 - $57,122	176 Added 19.09%	1,098 $312,000
Q4 2023 Feb 05, 2024	SELL	$255.7 - $288.46 $18,666 - $21,057	-73 Reduced 7.34%	922 $265,000
Q3 2023 Nov 15, 2023	SELL	$218.65 - $271.46 $5,466 - $6,786	-25 Reduced 2.45%	995 $267,000
Q2 2023 Aug 07, 2023	SELL	$214.27 - $253.37 $11,570 - $13,681	-54 Reduced 5.03%	1,020 $226,000
Q1 2023 May 08, 2023	BUY	$225.79 - $275.2 $677 - $825	3 Added 0.28%	1,074 $259,000
Q4 2022 Feb 14, 2023	SELL	$229.03 - $291.01 $25,193 - $32,011	-110 Reduced 9.31%	1,071 $281,000
Q3 2022 Oct 18, 2022	BUY	$224.46 - $253.15 $224 - $253	1 Added 0.08%	1,181 $266,000
Q2 2022 Jul 29, 2022	SELL	$230.71 - $256.74 $2,768 - $3,080	-12 Reduced 1.01%	1,180 $287,000
Q1 2022 May 11, 2022	BUY	$219.27 - $242.57 $219 - $242	1 Added 0.08%	1,192 $288,000
Q4 2021 Feb 08, 2022	BUY	$198.88 - $227.6 $7,955 - $9,104	40 Added 3.48%	1,191 $268,000
Q3 2021 Nov 12, 2021	SELL	$212.27 - $248.7 $29,505 - $34,569	-139 Reduced 10.78%	1,151 $245,000
Q2 2021 Aug 09, 2021	BUY	$233.58 - $259.14 $54,657 - $60,638	234 Added 22.16%	1,290 $314,000
Q1 2021 May 12, 2021	BUY	$221.91 - $258.6 $131,148 - $152,832	591 Added 127.1%	1,056 $263,000
Q4 2020 Feb 05, 2021	BUY	$216.38 - $257.67 $3,029 - $3,607	14 Added 3.1%	465 $107,000
Q2 2020 Aug 04, 2020	BUY	$197.81 - $242.74 $8,110 - $9,952	41 Added 10.0%	451 $106,000
Q4 2019 Feb 11, 2020	SELL	$189.21 - $243.2 $35,003 - $44,992	-185 Reduced 31.09%	410 $99,000
Q3 2019 Nov 05, 2019	SELL	$174.11 - $208.62 $5,571 - $6,675	-32 Reduced 5.1%	595 $115,000
Q1 2019 May 07, 2019	SELL	$180.87 - $203.88 $4,340 - $4,893	-24 Reduced 3.69%	627 $119,000
Q4 2018 May 07, 2019	BUY	$178.4 - $208.25 $6,422 - $7,497	36 Added 5.85%	651 $127,000
Q3 2018 Nov 13, 2018	BUY	$185.29 - $208.89 $5,002 - $5,640	27 Added 4.59%	615 $128,000
Q2 2018 Aug 07, 2018	SELL	$166.05 - $186.51 $10,793 - $12,123	-65 Reduced 9.95%	588 $108,000
Q1 2018 May 22, 2018	SELL	$169.43 - $198.0 $6,268 - $7,326	-37 Reduced 5.36%	653 $111,000
Q4 2017 Mar 19, 2018	BUY	$168.79 - $188.59 $116,465 - $130,127	690	690 $120,000

Others Institutions Holding AMGN

# of Institutions

3,125

Shares Held

409M

Call Options Held

7.56M

Put Options Held

7.2M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $140B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Mc Ilrath & Eck, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Mc Ilrath & Eck, LLC with notifications on news.

Account